SCOTBAKE LIMITED

Financial Health Score: B+

Explanation: Scotbake Limited exhibits a robust financial constitution with a strong asset base, healthy liquidity, and no long-term debt. However, the presence of interest-free director loans with no fixed repayment terms and a notable reduction in employee headcount introduce slight irregularities that prevent a perfect score. The business is financially stable but should monitor its internal lending and operational scaling closely.

1. Key Vital Signs

• Blood Pressure (Liquidity): Steady and Normal. The company’s current assets (£832,165) comfortably exceed current liabilities (£572,898), yielding a current ratio of approximately 1.45. This indicates a healthy circulatory system; the business has plenty of liquid resources to meet its short-term obligations without needing to sell off long-term assets.
• Heart Rate (Net Asset Growth): Strong Pulse. Net assets grew from £1,590,040 in 2024 to £1,671,961 in 2025, an increase of £81,921. Shareholders' funds are robust at nearly £1.7 million, showing a solid foundation of retained wealth.
• Cholesterol (Liabilities): Low Risk. Long-term creditors have been completely cleared, dropping from £4,541 to £0. Current liabilities have also been reduced from £603,800 to £572,898. The reduction in the deferred tax provision (from £199,545 down to £98,228) also represents a significant clearing of financial "blockages."
• White Blood Cell Count (Cash Reserves): Excellent Immunity. Cash at bank and in hand has increased from £375,769 to £426,839. This strong cash position acts as an excellent immune system against unexpected economic shocks or trading disruptions.

2. Diagnosis

Overall Condition: Healthy, with minor irregularities requiring observation.

Scotbake Limited presents the financial profile of a mature, asset-rich business in excellent short-term health. The balance sheet is fundamentally strong, underpinned by substantial tangible assets (£1,510,922) primarily in land and buildings, and a very healthy cash pile. The business is clearly generating solid working capital, and the complete elimination of long-term debt is an excellent sign of financial discipline.

However, looking beneath the surface, there are a few symptoms that warrant attention:

• Director Advances (Internal Bleeding Risk): The directors (Derek Smith and Christina Smith) have outstanding loan balances with the company totaling over £82,000 (£62,670 and £19,967 respectively). These advances are interest-free and have no fixed terms of repayment. While not immediately fatal to the cash flow, this represents capital that is tied up outside the business without a guaranteed return or repayment schedule. It is a mild irregularity in an otherwise healthy system.
• Workforce Contraction (Muscle Loss): The average monthly employee count dropped significantly from 53 to 41. While this may have been a necessary measure to protect profit margins or a result of operational efficiencies, a near-23% reduction in staff is a notable symptom. If this represents a loss of operational capacity rather than a strategic streamline, it could impact the business's ability to generate future revenue.
• Deferred Tax Release (Artificial Vitality): A significant portion of the £81,921 increase in net assets is attributable to the reduction in the deferred tax provision (a decrease of £101,317). While this improves the balance sheet, it is a non-cash accounting adjustment rather than cash generated from trading operations. The underlying trading profitability for the year would need to be assessed independently of this accounting credit.

3. Recommendations

To maintain and improve this healthy financial condition, the following preventative measures and treatments are recommended:

1. Formalise Director Loan Agreements: The interest-free, unsecured director loans should be placed on a formal, documented repayment schedule. This protects the company's cash flow and ensures that shareholder funds are working for the benefit of the entire business rather than sitting in personal accounts.
2. Review Operational Capacity: Conduct a health check on the operational impact of the 22% reduction in headcount. Ensure that the remaining 41 staff members are not overworked, which could lead to quality control issues in the bakery and distribution operations, and confirm that the reduction was a strategic efficiency gain rather than a desperate cost-cutting measure.
3. Strategic Cash Deployment: With over £426,000 sitting in the bank, the business has an excellent opportunity. Consider whether this "resting" cash could be better utilized—whether through paying down more current liabilities, investing in new plant and machinery to drive growth, or returning value to shareholders through formal dividend declarations rather than informal director advances.